The launch of a 750mcg parathyroid hormone injection in Australia has been cautiously managed, with availability primarily to specialist endocrinologists and designated hospitals . Preliminary sales figures for this concentrated formulation remain unavailable from the manufacturer , although industry sources suggest controlled adoption uptake level